Segundo González-Rodríguez

13PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 10, 2023
Chemo-Immunotherapy: A New Trend in Cancer Treatment.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez

|Dec 11, 2022
The Emerging Role of NK Cells in Immune Checkpoint Blockade.

Alejandra Martinez-Perez, Candelaria Aguilar-Garcia, Segundo Gonzalez

|Sep 09, 2022
Immunoglobulin-like transcript 2 blockade restores antitumor immune responses in glioblastoma.

Seila Lorenzo-Herrero, Christian Sordo-Bahamonde, Alejandra Martínez-Pérez

|Apr 26, 2022
Cystatin C-Based Equations Detect Hidden Kidney Disease and Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.

Francisco-Javier Cepeda-Piorno, Esther González-García, Alba Méndez-Gallego

|Apr 30, 2021
LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P González-Rodríguez

|Apr 30, 2021
BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia.

Christian Sordo-Bahamonde, Seila Lorenzo-Herrero, Ana P Gonzalez-Rodriguez

Pageof 3